Ferretti Simone, Dell'Oglio Paolo, Ciavarella Davide, Galfano Antonio, Schips Luigi, Marchioni Michele
Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Urology Unit, Chieti, Italy.
Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Res Rep Urol. 2023 Dec 12;15:541-552. doi: 10.2147/RRU.S372803. eCollection 2023.
Robotic-assisted radical prostatectomy (RARP) is the gold standard for localized prostate cancer. Several RARP approaches were developed and described over the years, aimed at improving oncological and functional outcomes. In 2010, Galfano et al described a new RARP technique, known as Retzius-sparing RARP (RS-RARP), a posterior approach through the Douglas space that spares the anterior support structures involved with urinary continence and sexual potency. This approach has been used increasingly in many centers around the world comparing its results with those of the most used standard anterior approach. Several randomized controlled trials, systematic reviews and meta-analyses demonstrated an important advantage relative to standard anterior RARP in terms of early urinary continence recovery, with comparable perioperative and long-term oncological outcomes. Several surgeons are concerned regarding RS-RARP because it appears to increase the risk of positive surgical margins (PSMs). However, this statement is based on low-certainty evidence. Indeed, the available studies compared the results of surgeons who had an initial experience with posterior RARP with those who had a solid experience with anterior RARP. Recent evidence strongly suggests that RS-RARP is feasible and safe not only in low- and intermediate-risk prostate cancer patient but also in challenging scenario such as high-risk setting, salvage prostatectomy and after transurethral resection of the prostate.
机器人辅助根治性前列腺切除术(RARP)是局限性前列腺癌的金标准。多年来,人们开发并描述了几种RARP手术方法,旨在改善肿瘤学和功能预后。2010年,加尔法诺等人描述了一种新的RARP技术,即保留Retzius间隙的RARP(RS-RARP),这是一种通过Douglas间隙的后路手术,保留了与尿失禁和性功能相关的前部支撑结构。与最常用的标准前路手术相比,这种手术方法在世界许多中心越来越多地被使用。多项随机对照试验、系统评价和荟萃分析表明,与标准前路RARP相比,RS-RARP在早期尿失禁恢复方面具有重要优势,围手术期和长期肿瘤学预后相当。一些外科医生对RS-RARP感到担忧,因为它似乎增加了手术切缘阳性(PSM)的风险。然而,这一说法基于低确定性证据。事实上,现有研究将初次进行后路RARP手术的外科医生的结果与经验丰富的前路RARP手术医生的结果进行了比较。最近的证据有力地表明,RS-RARP不仅在低危和中危前列腺癌患者中可行且安全,而且在高危情况、挽救性前列腺切除术和经尿道前列腺切除术后等具有挑战性的情况下也可行且安全。